Market Place
Sourcing Support
Ono Partners with Congruence for Oncology Drug Discovery
05 Dec 2024 //
PR NEWSWIRE
Congruence, Ono Partner for Cancer Small Molecule Correctors
03 Dec 2024 //
PR NEWSWIRE
Ono inks $700M biobuck deal to bag preclinical LigaChem ADC
12 Oct 2024 //
FIERCE BIOTECH
Kinaxis to Bolster Supply Chain Operations of Ono Pharmaceutical
07 Oct 2024 //
BUSINESSWIRE
Turbine Achieves Key Milestone in Collaboration with Ono Pharmaceutical
12 Sep 2024 //
BUSINESSWIRE
FDA Accepts Deciphera`s NDA For Vimseltinib For TGCT Treatment Under Review
15 Aug 2024 //
BUSINESSWIRE
EMA Accepts Deciphera`s MAA For Vimseltinib In TGCT
18 Jul 2024 //
BUSINESSWIRE
ONO PHARMA USA Announces Support for Conquer Cancer®, the ASCO Foundation
25 Jun 2024 //
PR NEWSWIRE
Ono Acquires Deciphera Pharmaceuticals
12 Jun 2024 //
CONTRACT PHARMA
Deciphera had another bidder before Ono deal
13 May 2024 //
ENDPTS
ONO PHARMA Accepting Startup Applications For Golden Ticket
02 May 2024 //
PR NEWSWIRE
Japan`s Ono to buy US drugmaker Deciphera for $2.4 bln
30 Apr 2024 //
REUTERS
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
29 Apr 2024 //
BUSINESSWIRE
Sibylla Biotech Enters a Drug Discovery Collaboration with Ono Pharmaceutical
14 Mar 2024 //
BUSINESSWIRE
Ono Enters into a Research Collaboration Agreement with InveniAI
20 Feb 2024 //
PR NEWSWIRE
Ono Enters into a Drug Discovery Collaboration with Shattuck Labs
14 Feb 2024 //
PR NEWSWIRE
Numab Therapeutics and Ono Pharmaceutical Announce an Option Agreement
14 Feb 2024 //
GLOBENEWSWIRE
Shattuck Enters into Strategic Collaboration and License Agreement with Ono
13 Feb 2024 //
GLOBENEWSWIRE
Call for Application to Researchers for Joint Project between Ono and BioMed X
09 Jan 2024 //
PR NEWSWIRE
Ono Enters into Collaboration Agreement with EVQLV
21 Dec 2023 //
PR NEWSWIRE
Turbine Establishes Research Collaboration with Ono Pharmaceutical
24 Oct 2023 //
BUSINESSWIRE
Ono Enters into a Drug Discovery Collaboration Agreement with Adimab
27 Sep 2023 //
PR NEWSWIRE
HiRO acquires US CRO Courante Oncology, strengthens global footprint
31 Aug 2023 //
PR NEWSWIRE
Twist Bioscience Enters into Agreement with Ono to Discover Novel Antibodies
31 Aug 2023 //
BUSINESSWIRE
ONO PHARMA USA Announces 2023 Golden Ticket Competition in Partnership
18 Apr 2023 //
PR NEWSWIRE
Ono Pharma`s Tirabrutinib Receives Orphan Drug Designation from the FDA
23 Mar 2023 //
PR NEWSWIRE
Macomics, Ono Pharmaceutical Partner to Develop Immuno-oncology Antibody Drugs
23 Mar 2023 //
CONTRACT PHARMA
Taiwan approves Ono Pharma`s non-small cell lung cancer drug with chemotherapy
24 Feb 2023 //
BIOSPECTRUM ASIA
Cue Biopharma Enters into Collaboration with Ono Pharmaceutical for CUE-401
22 Feb 2023 //
GLOBENEWSWIRE
Japan`s Ono signs up for KSQ`s preclinical cancer programs
26 Jan 2023 //
BUSINESSWIRE
Repare Therapeutics Receives $1.5M Payment from Ono Pharmaceuticals
19 Jan 2023 //
BUSINESSWIRE
Ono Pharmaceutical enters research deal with Monash University
16 Jan 2023 //
PHARMACEUTICAL TECHNOLOGY
PrecisionLife Enters into a R&D Collaboration Agreement with Ono Pharma
14 Dec 2022 //
GLOBENEWSWIRE
Equillium and Ono Pharmaceutical Announce Agreement for Itolizumab
06 Dec 2022 //
BUSINESSWIRE
Notice Concerning the Establishment of Michiteku Co., Ltd.
16 Nov 2022 //
PRESS RELEASE
Ono Pharma & Captor Therapeutics Announce Drug Discovery Collaboration
14 Nov 2022 //
GLOBENEWSWIRE
Ono and NS Solutions Jointly Build “OASIS”
11 Nov 2022 //
PRESS RELEASE
Ono Exercises Option to HER2-targeted CAR T-Cell Product Candidate
07 Nov 2022 //
PRESS RELEASE
Ono Enters a Drug Discovery Collaboration Agreement with Memo Therapeutics
01 Nov 2022 //
PRESS RELEASE
Memo AG and Ono Pharmaceutical Enter Antibody Discovery Partnership
31 Oct 2022 //
BUSINESSWIRE
ONO continues to expand its organization for enhancement of R&D activities
31 Aug 2022 //
PRNEWSWIRE
Fate Tx Announces Expansion of Solid Tumor Collaboration with ONO Pharmaceutical
28 Jun 2022 //
GLOBENEWSWIRE
Numab Therapeutics, Ono Pharmaceutical Enter Development and License Agreement
30 Mar 2022 //
BUSINESSWIRE
Neurimmune expands drug discovery collaboration with Ono Pharmaceutical
17 Jan 2022 //
PRNEWSWIRE
Opdivo wins Japanese nod for gastric, oesophageal cancer indications
26 Nov 2021 //
FIRSTWORDPHARMA
ONO PHARMA USA Announces Initiation of Phase 1 Study of ONO-4685
19 Oct 2021 //
PRNEWSWIRE
Caris & Ono Collaborate for Caris` Blood-Based cNAS Molecular Profiling Assay
14 Oct 2021 //
PRNEWSWIRE
Applications Submitted for Combination Therapy of Opdivo + Yervoy in Japan
14 Sep 2021 //
PRESS RELEASE
Opdivo Received Approval to Expand its Use in Combination with Yervoy in Taiwan
08 Sep 2021 //
PRESS RELEASE
Exelixis partner Takeda & Ono bag Japanese approval for Cabometyx +Opdivo in RCC
27 Aug 2021 //
PHARMABIZ
Takeda and Ono Receive Approval for CABOMETYX® in Combination with OPDIVO®
25 Aug 2021 //
BUSINESSWIRE
BRAFTOVI Approved in South Korea for Treatment of Colorectal Cancer
20 Aug 2021 //
PRESS RELEASE
Phase 2 Clinical Study Initiated for Velexbru (tirabrutinib)
19 Jul 2021 //
FIRSTWORDPHARMA
Revision of Package Insert of Opdivo with Bevacizumab
21 Jun 2021 //
PRESS RELEASE
Opdivo and Yervoy Combination Therapy Approved in Japan for First-line Treatment
27 May 2021 //
PRESS RELEASE
ONO Submits Supplemental Application for Approval for Opdivo®
14 Apr 2021 //
ONO-PHARMA
Ribon Announces License Agreement with Ono Pharmaceutical Co., Ltd. to Develop
02 Feb 2021 //
BIOSPACE
ONO Receives a Manufacturing and Marketing Approval of Adlumiz®
22 Jan 2021 //
GLOBENEWSWIRE
Chordia and Ono Pharmaceutical Enter into Exclusive License Agreement
15 Dec 2020 //
PRESS RELEASE
ONO Submits Application for Approval for Opdivo® (Nivolumab)
10 Dec 2020 //
ONO
